| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028029 |
| Receipt No. | R000032095 |
| Official scientific title of the study | Impact of LDL-particle Size in Coronary Artery Disease Patients with Type 2 Diabetes |
| Date of disclosure of the study information | 2017/07/01 |
| Last modified on | 2018/12/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Impact of LDL-particle Size in Coronary Artery Disease Patients with Type 2 Diabetes | |
| Title of the study (Brief title) | Evaluation of DM and estimated LDL-particle size | |
| Region |
|
|
| Condition | |||
| Condition | Consecutive outpatients with the presence of one or more risk factors for atherosclerosis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose of this study was to evaluate the LDL-C/apoB ratio as a marker of LDL-particle size in CAD patients with DM in a hospital-based cross-sectional/longitudinal study, and to assess LDL-particle size in relation to TG metabolism using TRL-related markers (TG, very LDL [VLDL], remnant-like particle cholesterol [RLP-C], apolipoprotein (apo) C-II, and apo C-III) as indicators. |
| Basic objectives2 | Others |
| Basic objectives -Others | In addition, we examined the relationships among the changes in the LDL-C/apoB ratio and changes in the TRL-related markers in those cases that were still available for additional measurements 6 months later. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Relatioship between coronary artery disease patient with type 2 diabetes and LDL particle size. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The study was conducted on a sample of
700 consecutive outpatients with the presence of one or more risk factors for CAD, who had undergone regular examinations for treatment of their various disease at the Cardiovascular Center, Nihon University Surugadai Hospital between April 2009 and October 2009. |
|||
| Key exclusion criteria | Patients were not enrolled if they met
any of the following exclusion criteria: hepatic dysfunction, known malignant disease, or diagnosis of acute coronary syndrome within 3 months prior to the study. |
|||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Shigemasa Tani |
| Organization | Nihon University Hospital |
| Division name | Department of Cardiology |
| Address | 1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan |
| TEL | 03-3293-1711 |
| tanishigem@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Shigemasa Tani |
| Organization | Nihon University Hospital |
| Division name | Department of Cardiology |
| Address | 1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan |
| TEL | 03-3293-1711 |
| Homepage URL | |
| tanishigem@yahoo.co.jp | |
| Sponsor | |
| Institute | Nihon University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nihon University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | This study is cross-sectional sudy.
The study was conducted on a sample of 700 consecutive outpatients with the presence of one or more risk factors for CAD, who had undergone regular examinations for treatment of their various disease at the Cardiovascular Center, Nihon University Surugadai Hospital between April 2009 and October 2009. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032095 |